Theseus Pharmaceuticals Stock Forecast, Price & News

Theseus Pharmaceuticals (NASDAQ:THRX) Frequently Asked Questions

Is Theseus Pharmaceuticals a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Theseus Pharmaceuticals in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Theseus Pharmaceuticals stock.
View analyst ratings for Theseus Pharmaceuticals or view top-rated stocks.

When is Theseus Pharmaceuticals' next earnings date?

Theseus Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, February 21st 2022.
View our earnings forecast for Theseus Pharmaceuticals.

How were Theseus Pharmaceuticals' earnings last quarter?

Theseus Pharmaceuticals Inc (NASDAQ:THRX) issued its quarterly earnings data on Monday, November, 15th. The company reported ($5.16) earnings per share for the quarter, missing analysts' consensus estimates of ($0.23) by $4.93.
View Theseus Pharmaceuticals' earnings history.

What price target have analysts set for THRX?

4 brokers have issued 12-month price objectives for Theseus Pharmaceuticals' stock. Their forecasts range from $23.00 to $28.00. On average, they anticipate Theseus Pharmaceuticals' stock price to reach $25.00 in the next twelve months. This suggests a possible upside of 75.6% from the stock's current price.
View analysts' price targets for Theseus Pharmaceuticals or view top-rated stocks among Wall Street analysts.

When did Theseus Pharmaceuticals IPO?

(THRX) raised $150 million in an initial public offering (IPO) on Thursday, October 7th 2021. The company issued 10,000,200 shares at a price of $14.00-$16.00 per share.

What is Theseus Pharmaceuticals' stock symbol?

Theseus Pharmaceuticals trades on the NASDAQ under the ticker symbol "THRX."

When did Theseus Pharmaceuticals' quiet period expire?

Theseus Pharmaceuticals' quiet period expired on Tuesday, November 16th. Theseus Pharmaceuticals had issued 10,000,200 shares in its IPO on October 7th. The total size of the offering was $160,003,200 based on an initial share price of $16.00. During Theseus Pharmaceuticals' quiet period, insiders and any underwriters involved in the IPO were restricted from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Theseus Pharmaceuticals?

Shares of THRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Theseus Pharmaceuticals' stock price today?

One share of THRX stock can currently be purchased for approximately $14.24.

How much money does Theseus Pharmaceuticals make?

Theseus Pharmaceuticals has a market capitalization of $551.13 million.